It is debated whether this definition may prevent shifting scientific attention to other relevant candidate factors contributing to AD—which might lead to missing mechanistic cascades beyond Abeta and Tau proteins (Gauthier et al., 2018). The gene discussed is MAPT; the disease is Alzheimer disease.